Internal Medicine · Johnston, RI
NPI
1063640225
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1524 Atwood Ave, Suite 333
Johnston, RI, 02919
Phone (401) 421-6011
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
154,655 services
Medicare patients, 2024
365
Average age 75
Drug cost, 2024
$2.5M
2,592 prescriptions
Company payments, 2023
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kiley Toder was code J3262 (injection, tocilizumab, 1 mg), 60,984 times for 11 patients. In total Kiley Toder billed 154,655 services in 28 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 60,984 | 11 | $4.71 | $287K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 41,600 | 11 | $3.61 | $150K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 18,550 | 18 | $9.13 | $169K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 12,100 | 19 | $33.83 | $409K |
| J0897 Injection, denosumab, 1 mg | Office | 6,300 | 74 | $20.66 | $130K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 3,003 | 15 | $23.38 | $70K |
| 99213 Office E&M - Established | Office | 451 | 240 | $67.58 | $30K |
| 96413 Chemotherapy Administration | Office | 423 | 72 | $97.37 | $41K |
| 99214 Office E&M - Established | Office | 349 | 218 | $91.67 | $32K |
| 96372 Injection Administration | Office | 150 | 79 | $11.44 | $1,715 |
| 96401 Chemotherapy Administration | Office | 138 | 11 | $55.02 | $7,593 |
| 96415 Chemotherapy Administration | Office | 113 | 27 | $21.95 | $2,480 |
| 96365 Intravenous Infusion, Hydration | Office | 95 | 32 | $46.83 | $4,449 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 95 | 19 | $5.03 | $478 |
| 99203 Office E&M - New | Office | 14 | 14 | $84.85 | $1,188 |
By year: 2022 $522K for 48,021 services; 2023 $1.3M for 122,969 services; 2024 $1.5M for 154,655 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kiley Toder prescribed most often to Medicare patients was Allopurinol, with 474 prescriptions and refills. In total Kiley Toder wrote 2,592 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 474 | 1,328 | 113 | $7,312 |
| Methotrexate Methotrexate Sodium | 373 | 912 | 101 | $11K |
| Prednisone Generic | 220 | 337 | 64 | $1,519 |
| Alendronate Sodium Generic | 174 | 424 | 46 | $2,093 |
| Hydroxychloroquine Sulfate Generic | 159 | 369 | 43 | $6,853 |
| Celecoxib Generic | 114 | 246 | 34 | $3,421 |
| Meloxicam Generic | 112 | 234 | 32 | $765 |
| Enbrel Sureclick Etanercept | 92 | 92 | Under 11 | $700K |
| Colchicine Generic | 83 | 167 | 33 | $5,828 |
| Xeljanz Tofacitinib Citrate | 79 | 81 | Under 11 | $458K |
| Leucovorin Calcium Generic | 69 | 191 | 24 | $912 |
| Humira(Cf) Pen Adalimumab | 59 | 59 | Under 11 | $433K |
| Folic Acid Generic | 45 | 133 | 15 | $458 |
| Sulfasalazine Generic | 37 | 85 | 12 | $1,253 |
| Leflunomide Generic | 32 | 88 | 11 | $3,234 |
Brand drugs: - claims; generic drugs: 2,154 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Kiley Toder $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $125.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.